NDRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $124,749.60

Insider Selling (Last 12 Months): $0.00

ENDRA Life Sciences Insider Trading History Chart

ENDRA Life Sciences Share Price & Price History

^$0.25

▲ +0.01 (4.12%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

ENDRA Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/18/2023	Michael Milos Thornton	CTO	Buy	15,000	$1.65	$24,750.00	34,139
5/2/2023	Anthony Digiandomenico	Director	Buy	83,333	$1.20	$99,999.60	102,434
12/9/2022	Michael Milos Thornton	CTO	Buy	1,500	$3.40	$5,100.00	19,139
11/23/2022	Alexander Y Tokman	Director	Buy	10,000	$0.17	$1,700.00	162,857
8/22/2022	Michael Milos Thornton	CTO	Buy	20,000	$0.27	$5,400.00	352,775
5/26/2022	Michael Milos Thornton	CTO	Buy	25,000	$0.21	$5,250.00	332,775
5/18/2022	Michael Milos Thornton	CTO	Buy	25,000	$0.22	$5,500.00	307,775
5/17/2022	Francois Roger Michelon	CEO	Buy	5,100	$0.19	$969.00	97,191
8/25/2021	Lou Basenese	Director	Sell	45,000	$1.83	$82,350.00

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for ENDRA Life Sciences (NASDAQ:NDRA)

1.19% of ENDRA Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ENDRA Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/8/2022	Raymond James & Associates	70,854	$49K	0.0%	N/A	0.168%
8/16/2021	State Street Corp	60,300	$0.13M	0.0%	N/A	0.145%
8/16/2021	Goldman Sachs Group Inc.	47,709	$0.10M	0.0%	N/A	0.114%
8/13/2021	Stifel Financial Corp	12,500	$27K	0.0%	N/A	0.030%
8/13/2021	Geode Capital Management LLC	316,482	$0.69M	0.0%	+23.5%	0.759%
8/13/2021	Vanguard Group Inc.	1,709,100	$3.73M	0.0%	+8.1%	4.101%
8/2/2021	Advisor Group Holdings Inc.	44,037	$96K	0.0%	+4,407.4%	0.106%
7/31/2021	GWM Advisors LLC	705,439	$1.54M	0.0%	N/A	1.693%
7/23/2021	Tranquility Partners LLC	12,750	$28K	0.0%	N/A	0.031%
5/21/2021	Citadel Advisors LLC	49,856	$0.13M	0.0%	N/A	0.120%
5/18/2021	Citadel Advisors LLC	49,856	$0.13M	0.0%	N/A	0.120%
5/17/2021	Royal Bank of Canada	15,310	$40K	0.0%	N/A	0.037%
5/14/2021	K.J. Harrison & Partners Inc	65,000	$0.17M	0.0%	-76.6%	0.156%
5/13/2021	Capital Asset Advisory Services LLC	10,065	$26K	0.0%	N/A	0.024%
5/13/2021	Blair William & Co. IL	35,000	$91K	0.0%	N/A	0.084%
5/12/2021	Northern Trust Corp	63,378	$0.17M	0.0%	+112.8%	0.152%
5/12/2021	Geode Capital Management LLC	256,300	$0.67M	0.0%	+300.9%	0.616%
5/12/2021	UBS Group AG	30,513	$79K	0.0%	+399.9%	0.073%
5/4/2021	Ieq Capital LLC	17,111	$44K	0.0%	N/A	0.041%
5/3/2021	Flagship Harbor Advisors LLC	697,026	$1.81M	0.2%	N/A	1.676%
5/3/2021	55I LLC	88,850	$0.23M	0.0%	N/A	0.214%
2/17/2021	Worth Venture Partners LLC	329,420	$0.25M	0.2%	N/A	1.000%
2/16/2021	HN Saltoro Capital LP	193,855	$0.15M	0.1%	N/A	0.589%
2/10/2021	Renaissance Technologies LLC	86,400	$65K	0.0%	N/A	0.262%
2/8/2021	K.J. Harrison & Partners Inc	277,629	$0.21M	0.0%	+60.9%	0.843%
12/11/2020	Virtu Financial LLC	41,738	$31K	0.0%	+62.5%	0.127%
8/17/2020	Gladstone Institutional Advisory LLC	36,300	$35K	0.0%	N/A	0.222%
8/7/2020	Virtu Financial LLC	25,681	$25K	0.0%	N/A	0.157%
7/27/2020	ICM Asset Management Inc. WA	401,861	$0.39M	2.0%	-54.2%	2.455%
5/7/2020	ICM Asset Management Inc. WA	876,639	$0.63M	0.6%	+32.0%	6.374%

Data available starting January 2016

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Today's Range

Now: $0.25

$0.24

$0.26

50 Day Range

MA: $0.75

$0.23

$1.21

52 Week Range

Now: $0.25

$0.22

$2.79

Volume

11,072 shs

Average Volume

161,098 shs

Market Capitalization

$2.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Who are the company insiders with the largest holdings of ENDRA Life Sciences?: ENDRA Life Sciences' top insider investors include:
Michael Milos Thornton (CTO)
Alexander Y Tokman (Director)
Anthony Digiandomenico (Director)
Francois Roger Michelon (CEO)
Learn More about top insider investors at ENDRA Life Sciences.